McElhiney Linda F
Indiana University of Health, Indianapolis, Indiana.
Int J Pharm Compd. 2020 Jul-Aug;24(4):287-295.
The year 2020 will infamously be known for the COVID-19 pandemic. It certainly caught most of the population completely off-guard and forever changed their lives. Unfortunately, this pandemic is expected to make a resurgence in the fall, but hopefully more will be known about SARS-CoV-2, better treatment protocols will be established, and, possibly, a safe and effective vaccine will be developed and available soon. There are numerous drug shortages due to the COVID-19 pandemic. Some products are not commercially available in certain dosage forms needed by patients. Pharmacies (retail, independents, health systems) all over the U.S. are being asked to compound items such as hand sanitizers, saccharin solutions for FIT testing of N95 masks, and hydroxychloroquine suspension. The commercial lopinavir/ritonavir oral liquid is in short supply and may need to be compounded soon. We are all in this one together, from the essential workers to the children, and pharmacists are emerging as one of the first-line responders.
2020年将因新冠疫情而臭名远扬。它无疑让大多数人完全措手不及，并永远改变了他们的生活。不幸的是，预计这场疫情在秋季会卷土重来，但有望人们对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）有更多了解，能建立更好的治疗方案，并且可能很快会研发出安全有效的疫苗并可供使用。由于新冠疫情，出现了大量药品短缺的情况。有些产品没有患者所需的特定剂型的商业供应。美国各地的药店（零售药店、独立药店、医疗系统药店）都被要求配制诸如洗手液、用于N95口罩适合性测试的糖精溶液以及羟氯喹悬浮液等物品。商用洛匹那韦/利托那韦口服液供应短缺，可能很快需要进行配制。从一线工作者到儿童，我们都身处这场疫情之中，药剂师正成为一线应对者之一。
